Resmed Inc Stock Probability Of Bankruptcy

RMD Stock  USD 198.03  1.70  0.87%   
ResMed's odds of distress is less than 5% at the present time. It is unlikely to undergo any financial crunch in the next 24 months. ResMed's Probability Of Bankruptcy is determined by interpolating and adjusting ResMed Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the ResMed balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out ResMed Piotroski F Score and ResMed Altman Z Score analysis.
  

ResMed Probability Of Bankruptcy Analysis

ResMed's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
 2021 2022 2023 2024 (projected)
Gross Profit2.0B2.4B2.7B2.8B
Total Revenue3.6B4.2B4.9B5.1B

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current ResMed Probability Of Bankruptcy

    
  Less than 5%  
Most of ResMed's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ResMed Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of ResMed probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting ResMed odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of ResMed Inc financial health.
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
1.84
Earnings Share
6.05
Revenue Per Share
30.633
Quarterly Revenue Growth
0.125
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

ResMed Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for ResMed is extremely important. It helps to project a fair market value of ResMed Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since ResMed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ResMed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ResMed's interrelated accounts and indicators.
0.810.980.870.990.960.970.940.650.970.91-0.170.930.690.450.850.980.720.920.88-0.60.99-0.450.580.84-0.21-0.450.780.78-0.670.180.76
0.810.80.720.790.820.820.740.630.780.61-0.360.80.720.370.870.840.660.820.58-0.510.87-0.450.370.76-0.26-0.740.80.57-0.8-0.20.55
0.980.80.790.990.940.970.970.690.910.94-0.190.860.640.460.850.940.750.880.8-0.560.97-0.310.450.81-0.24-0.460.720.78-0.650.230.78
0.870.720.790.820.80.80.780.610.940.62-0.230.970.820.140.780.950.460.910.94-0.420.88-0.660.70.74-0.11-0.460.840.72-0.720.060.66
0.990.790.990.820.970.980.950.610.940.92-0.150.890.630.490.870.950.750.90.83-0.640.97-0.390.520.86-0.16-0.450.760.75-0.670.180.75
0.960.820.940.80.970.960.870.520.930.87-0.180.890.660.560.830.930.780.850.81-0.740.95-0.50.620.91-0.21-0.480.820.68-0.680.040.64
0.970.820.970.80.980.960.90.540.930.9-0.150.890.60.560.880.930.750.890.81-0.710.95-0.470.550.87-0.13-0.430.770.68-0.720.060.7
0.940.740.970.780.950.870.90.770.860.9-0.230.80.670.30.810.90.670.860.76-0.40.94-0.160.330.74-0.3-0.480.650.84-0.610.360.82
0.650.630.690.610.610.520.540.770.570.54-0.450.560.75-0.080.580.670.430.650.490.10.720.060.080.39-0.46-0.490.510.75-0.470.340.64
0.970.780.910.940.940.930.930.860.570.82-0.120.990.720.40.80.980.650.910.95-0.610.95-0.630.730.84-0.16-0.410.830.74-0.660.10.7
0.910.610.940.620.920.870.90.90.540.820.030.720.410.570.650.790.750.70.73-0.580.85-0.180.40.71-0.26-0.240.520.72-0.390.390.73
-0.17-0.36-0.19-0.23-0.15-0.18-0.15-0.23-0.45-0.120.03-0.2-0.490.16-0.37-0.24-0.13-0.37-0.12-0.11-0.270.020.09-0.120.210.52-0.34-0.230.480.2-0.17
0.930.80.860.970.890.890.890.80.560.990.72-0.20.770.340.810.980.590.930.95-0.570.93-0.710.750.82-0.14-0.470.870.7-0.740.00.66
0.690.720.640.820.630.660.60.670.750.720.41-0.490.770.050.640.790.530.740.68-0.230.77-0.430.510.67-0.46-0.620.840.77-0.660.070.49
0.450.370.460.140.490.560.560.3-0.080.40.570.160.340.050.320.320.810.280.28-0.840.39-0.320.420.64-0.02-0.110.430.29-0.270.040.16
0.850.870.850.780.870.830.880.810.580.80.65-0.370.810.640.320.870.590.930.65-0.550.87-0.410.330.80.07-0.610.790.59-0.87-0.130.64
0.980.840.940.950.950.930.930.90.670.980.79-0.240.980.790.320.870.650.950.91-0.540.98-0.550.630.84-0.18-0.50.860.77-0.740.090.73
0.720.660.750.460.750.780.750.670.430.650.75-0.130.590.530.810.590.650.560.5-0.690.72-0.230.430.84-0.27-0.380.710.73-0.440.280.47
0.920.820.880.910.90.850.890.860.650.910.7-0.370.930.740.280.930.950.560.83-0.490.93-0.530.510.79-0.08-0.590.820.7-0.83-0.020.72
0.880.580.80.940.830.810.810.760.490.950.73-0.120.950.680.280.650.910.50.83-0.50.84-0.660.790.71-0.11-0.230.750.71-0.540.180.67
-0.6-0.51-0.56-0.42-0.64-0.74-0.71-0.40.1-0.61-0.58-0.11-0.57-0.23-0.84-0.55-0.54-0.69-0.49-0.5-0.540.6-0.64-0.78-0.130.2-0.61-0.240.480.23-0.12
0.990.870.970.880.970.950.950.940.720.950.85-0.270.930.770.390.870.980.720.930.84-0.54-0.440.540.84-0.29-0.550.820.79-0.720.110.75
-0.45-0.45-0.31-0.66-0.39-0.5-0.47-0.160.06-0.63-0.180.02-0.71-0.43-0.32-0.41-0.55-0.23-0.53-0.660.6-0.44-0.87-0.53-0.150.23-0.67-0.140.520.46-0.11
0.580.370.450.70.520.620.550.330.080.730.40.090.750.510.420.330.630.430.510.79-0.640.54-0.870.65-0.02-0.030.720.37-0.38-0.10.23
0.840.760.810.740.860.910.870.740.390.840.71-0.120.820.670.640.80.840.840.790.71-0.780.84-0.530.65-0.1-0.440.910.69-0.710.040.56
-0.21-0.26-0.24-0.11-0.16-0.21-0.13-0.3-0.46-0.16-0.260.21-0.14-0.46-0.020.07-0.18-0.27-0.08-0.11-0.13-0.29-0.15-0.02-0.10.41-0.1-0.40.0-0.25-0.21
-0.45-0.74-0.46-0.46-0.45-0.48-0.43-0.48-0.49-0.41-0.240.52-0.47-0.62-0.11-0.61-0.5-0.38-0.59-0.230.2-0.550.23-0.03-0.440.41-0.51-0.390.670.23-0.33
0.780.80.720.840.760.820.770.650.510.830.52-0.340.870.840.430.790.860.710.820.75-0.610.82-0.670.720.91-0.1-0.510.68-0.79-0.10.49
0.780.570.780.720.750.680.680.840.750.740.72-0.230.70.770.290.590.770.730.70.71-0.240.79-0.140.370.69-0.4-0.390.68-0.440.610.77
-0.67-0.8-0.65-0.72-0.67-0.68-0.72-0.61-0.47-0.66-0.390.48-0.74-0.66-0.27-0.87-0.74-0.44-0.83-0.540.48-0.720.52-0.38-0.710.00.67-0.79-0.440.35-0.43
0.18-0.20.230.060.180.040.060.360.340.10.390.20.00.070.04-0.130.090.28-0.020.180.230.110.46-0.10.04-0.250.23-0.10.610.350.44
0.760.550.780.660.750.640.70.820.640.70.73-0.170.660.490.160.640.730.470.720.67-0.120.75-0.110.230.56-0.21-0.330.490.77-0.430.44
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, ResMed Inc has a Probability Of Bankruptcy of 5.0%. This is 88.45% lower than that of the Health Care Equipment & Supplies sector and 86.21% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 87.45% higher than that of the company.

ResMed Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ResMed's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ResMed could also be used in its relative valuation, which is a method of valuing ResMed by comparing valuation metrics of similar companies.
ResMed is currently under evaluation in probability of bankruptcy category among related companies.

ResMed Main Bankruptcy Drivers

201920202021202220232024 (projected)
Net Debt836.1M498.4M643.8M1.4B1.6B1.6B
Total Current Liabilities602.8M911.8M689.3M758.5M872.3M915.9M
Non Current Liabilities Total1.5B930.7M1.0B1.9B2.1B2.2B
Total Assets4.6B4.7B5.1B6.8B7.8B8.2B
Total Current Assets1.5B1.6B1.9B2.4B2.7B2.9B
Total Cash From Operating Activities802.3M736.7M351.1M693.3M797.3M837.2M

ResMed ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ResMed's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ResMed's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

ResMed Fundamentals

About ResMed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ResMed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ResMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ResMed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. ResMed operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 8160 people.

Currently Active Assets on Macroaxis

When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
Check out ResMed Piotroski F Score and ResMed Altman Z Score analysis.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for ResMed Stock analysis

When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Correlations
Find global opportunities by holding instruments from different markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
CEOs Directory
Screen CEOs from public companies around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Transaction History
View history of all your transactions and understand their impact on performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Is ResMed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
1.84
Earnings Share
6.05
Revenue Per Share
30.633
Quarterly Revenue Growth
0.125
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.